High throughput screening News and Research

RSS
High-throughput screening (HTS) allows scientists to test thousands of samples at once. These samples can be of a wide variety, and include, but are not limited to, amino acids, chemical compounds or cells.
GC product division celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics

GC product division celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics

Melbourne’s lab-grown "skin" revolutionizes tick research

Melbourne’s lab-grown "skin" revolutionizes tick research

Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs

Calibr-Skaggs and Kainomyx join forces to accelerate development of antimalarial drugs

SPT Labtech and Bellbrook Labs introduce high-throughput screening platform for cancer research

SPT Labtech and Bellbrook Labs introduce high-throughput screening platform for cancer research

Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026

Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026

Small molecule targets glioblastoma oncogene in preclinical studies

Small molecule targets glioblastoma oncogene in preclinical studies

Sino Biological's launch of SwiftFluo® TR-FRET Kits pioneers a new era in high- throughput kinase inhibitor screening

Sino Biological's launch of SwiftFluo® TR-FRET Kits pioneers a new era in high- throughput kinase inhibitor screening

Accelerating kinase drug discovery with validated kinase activity assay kits

Accelerating kinase drug discovery with validated kinase activity assay kits

Label-free polarized light reveals subtle red blood cell deformations

Label-free polarized light reveals subtle red blood cell deformations

Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers

Small molecule discovery could open the door to new class of treatments for hard-to-treat cancers

Freezing cells for success: DMSO-free redefining the future of cryopreservation

Freezing cells for success: DMSO-free redefining the future of cryopreservation

New medication offers potential treatment for patients with deadliest form of blood cancer

New medication offers potential treatment for patients with deadliest form of blood cancer

Terasaki Institute and Caltech join forces on groundbreaking embryo formation study

Terasaki Institute and Caltech join forces on groundbreaking embryo formation study

Redefining control and consistency in anaerobic microbiome workflows

Redefining control and consistency in anaerobic microbiome workflows

Merck partners with Promega to advance 3-D cell dug discovery technologies

Merck partners with Promega to advance 3-D cell dug discovery technologies

Microarray platform could help predict immune‐mediated drug‐induced liver injury

Microarray platform could help predict immune‐mediated drug‐induced liver injury

Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology

Axxam and B'SYS partner to expand access to validated ion channel cell lines for high-throughput electrophysiology

BindCraft reimagines protein binder discovery through structural prediction

BindCraft reimagines protein binder discovery through structural prediction

Mapping microbiomes across the food system to restore health

Mapping microbiomes across the food system to restore health

Introducing the iQue® 5 HTS Platform: empowering scientists with unbeatable speed and flexibility for high throughput screening by cytometry

Introducing the iQue® 5 HTS Platform: empowering scientists with unbeatable speed and flexibility for high throughput screening by cytometry

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.